Search
Search Results
##search.searchResults.foundPlural##
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2298PDF: 1327HTML: 17082Bassan Fig.1: 143Bassan Fig.2: 155Bassan Fig.4: 142Fig.3: 187 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4070PDF: 1934HTML: 5268Table 1: 191 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1704PDF: 696HTML: 3795 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2585PDF: 865HTML: 17563Fig1 Caligaris: 172Fig.2 Caliga: 205 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2212PDF: 1497HTML: 267 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2134PDF: 1697HTML: 378 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1277PDF: 489HTML: 137 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1762PDF: 878HTML: 375Fig1: 233Fig.2: 253Fig. 3: 182Fig. 5: 195Fig. 4: 223 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
955PDF: 1208HTML: 111 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9080PDF: 6063HTML: 87963Fig.1b: 185Fig.1c: 190Fig.2a: 177Fig.2b: 177Fig.4: 188Fig.2c: 185Fig.3: 184Tab.1: 228Tab.2: 207Tab.3: 190Tab.4: 222Fig1a: 186 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1593PDF: 1218HTML: 259 -
CAR-T cells microscopic and phenotypic identification in the peripheral blood CAR-T cells in the PB
1670PDF: 631HTML: 201 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1583PDF: 605HTML: 191 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2109PDF: 993HTML: 4071Cover Letter: 221Figure 1: 234Figure 2: 231Table 1: 204 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1837PDF: 718HTML: 2109Untitled: 218Untitled: 153Untitled: 172Untitled: 155Untitled: 164Untitled: 180Untitled: 185 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
847PDF: 487HTML: 1305 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1615PDF: 883HTML: 3155Figure 5: 154Figure 4: 158Figure 3: 192Figure 1: 170Figure 2: 166 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2782PDF: 1828HTML: 3668Pellagatti Fig 1: 214Pellagatti Fig. 2: 212 -
-
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3069PDF: 878HTML: 7164Kost Fig1: 184Kost Fig 2: 180Kost Fig3: 177Kost Fig 4: 191Kost Fig5: 186Kost fig 6: 174







